Davidson Capital Management’s Pfizer PFE Stock Holding History

Davidson Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-90	Closed	-$2.59K	–	123
2023 Q4	$2.59K	Sell	90 -34,168	-100%	-$1.03M	﹤0.01%	115
2023 Q3	$1.14M	Sell	34,258 -135	-0.4%	-$4.77K	0.56%	45
2023 Q2	$1.26M	Buy	34,393 +586	+2%	+$22.8K	0.63%	48
2023 Q1	$1.38M	Buy	33,807 +17,761	+111%	+$767K	0.84%	32
2022 Q4	$822K	Buy	+16,046	New	+$769K	0.56%	33

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Davidson Capital Management's PFE Position: Q1 2024 in Review

Davidson Capital Management sold out of Pfizer (PFE) in Q1 2024, closing a stake of 90 shares — an estimated $2.59K sold.

Davidson Capital Management first reported a position in PFE in Q4 2022 and held it in 5 quarters. The position peaked at $1.38M in Q1 2023. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

Davidson Capital Management reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
Davidson Capital Management sold 90 Pfizer shares in Q1 2024, an estimated $2.59K.
Davidson Capital Management first reported a position in Pfizer in Q4 2022 and held it in 5 quarters.
Davidson Capital Management's Pfizer position peaked at $1.38M in Q1 2023.
2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Davidson Capital Management's 13F filing for Q1 2024, filed 6 May 2024.